Stockscreener 앱 받기
77.17
3.49%
-2.79
시간 외 거래:
77.50
0.33
+0.43%
전일 마감가:
$79.96
열려 있는:
$79.73
하루 거래량:
5.26M
Relative Volume:
1.02
시가총액:
$44.43B
수익:
$6.30B
순이익/손실:
$1.07B
주가수익비율:
41.93
EPS:
1.8406
순현금흐름:
$1.09B
1주 성능:
-7.39%
1개월 성능:
-0.90%
6개월 성능:
-9.38%
1년 성능:
+4.74%
1일 변동 폭
$76.49
$80.08
1주일 범위
$76.49
$84.42
52주 변동 폭
$72.30
$87.89
에드워즈라이프사이언시스 Stock (EW) Company Profile
명칭
Edwards Lifesciences Corp
전화
(949) 250-2500
주소
ONE EDWARDS WAY, IRVINE, CA
Compare EW vs ABT, SYK, MDT, BSX
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-01 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2026-01-09 | 업그레이드 | TD Cowen | Hold → Buy |
| 2025-12-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-11-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-10-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-10-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-29 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-04-24 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Stifel | Hold → Buy |
| 2025-01-16 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-11 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-09-18 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-07-31 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-07-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-07-25 | 다운그레이드 | Truist | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-03-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-02-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-28 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | 다운그레이드 | Bernstein | Outperform → Underperform |
| 2023-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 개시 | Mizuho | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-27 | 재확인 | Citigroup | Buy |
| 2022-01-27 | 재확인 | Evercore ISI | Outperform |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | Stifel | Buy |
| 2022-01-27 | 재확인 | UBS | Neutral |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 재확인 | Canaccord Genuity | Buy |
| 2021-07-30 | 재확인 | Deutsche Bank | Hold |
| 2021-07-30 | 재확인 | Jefferies | Buy |
| 2021-07-30 | 재확인 | Morgan Stanley | Overweight |
| 2021-07-30 | 재확인 | Oppenheimer | Outperform |
| 2021-07-30 | 재확인 | Stifel | Buy |
| 2021-07-30 | 재확인 | UBS | Neutral |
| 2021-07-30 | 재확인 | Wells Fargo | Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-04-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-11 | 재확인 | Canaccord Genuity | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Underperform |
| 2020-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Outperform |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 재확인 | Canaccord Genuity | Buy |
| 2019-09-23 | 개시 | Piper Jaffray | Overweight |
| 2019-07-24 | 재확인 | BofA/Merrill | Buy |
| 2019-03-18 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Hold |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-10-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
모두보기
에드워즈라이프사이언시스 주식(EW)의 최신 뉴스
[144] Edwards Lifesciences Corp SEC Filing - Stock Titan
Edwards Lifesciences (EW) is Benefitting from Expanding Its Aortic Valve Franchise - Yahoo! Finance Canada
Nwam LLC Grows Position in Edwards Lifesciences Corporation $EW - MarketBeat
EW SEC FilingsEdwards Lifesciences Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Generali Asset Management SPA SGR Has $6.18 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE: EW) awards RSUs and options to CVP Daveen Chopra - Stock Titan
Edwards Lifesciences Corp (EW) Shares Fall 3.4% -- What GF Score of 97 Tells Investors - GuruFocus
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
Edwards Lifesciences (NYSE: EW) investors approve equity and pay measures - Stock Titan
Swedbank AB Sells 192,442 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Principal Financial Group Inc. Grows Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Top Edwards Lifesciences (EW) Competitors 2026 - MarketBeat
QRG Capital Management Inc. Acquires 18,172 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE: EW) lifts Q1 2026 sales on TAVR and TMTT growth - Stock Titan
[Form 4] Edwards Lifesciences Corp Insider Trading Activity - Stock Titan
Insider Sell: Daniel Lippis Sells Shares of Edwards Lifesciences Corp (EW) - GuruFocus
Edwards Lifesciences Appoints Theodora Mistras as Chief Financial Officer Effective May 2026 - Minichart
symbol__ Stock Quote Price and Forecast - CNN
Edwards Lifesciences CVP, TAVR, sells $170,160 in stock - Investing.com UK
Edwards Lifesciences CVP, TAVR, sells $170,160 in stock By Investing.com - Investing.com Canada
Edwards Lifesciences (EW) CVP Lippis sells 2,038 shares after option exercises - Stock Titan
Edwards Lifesciences (EW) executive logs 282-share tax withholding on Form 4 - Stock Titan
Edwards Lifesciences (EW) VP Donald Bobo logs tax share disposal and holdings - Stock Titan
Edwards Lifesciences names Doretta Mistras as new CFO - Investing.com
Theodora Mistras to Become Edwards Lifesciences CFO, Succeeding Scott Ullem - TradingView
New Edwards Lifesciences (NYSE: EW) CFO to receive $925K salary and major equity - Stock Titan
Edwards picks Viatris finance chief Doretta Mistras as CFO - Stock Titan
Edwards Lifesciences (NYSE: EW) files Form 144; insider disposals listed - Stock Titan
Possible Bearish Signals With Edwards Lifesciences Insiders Disposing Stock - Yahoo Finance
Edwards Lifesciences Corporation (EW) Stock Analysis: 15.68% Potential Upside Beckons Investors - DirectorsTalk Interviews
TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE - Yahoo Finance
PFA Pension Forsikringsaktieselskab Buys Shares of 543,261 Edwards Lifesciences Corporation $EW - MarketBeat
M&T Bank Corp Cuts Position in Edwards Lifesciences Corporation $EW - MarketBeat
After 10 years, Edwards valve tissue shows 97.9% freedom from deterioration - Stock Titan
Edwards Lifesciences Corporation $EW Stake Lessened by Kornitzer Capital Management Inc. KS - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Caisse Des Depots ET Consignations - MarketBeat
Exencial Wealth Advisors LLC Trims Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings - Insider Monkey
EW Technical Analysis | Trend, Signals & Chart Patterns | EDWARDS LIFESCIENCES CORP (NYSE:EW) - ChartMill
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Jennison Associates LLC Sells 178,259 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
How The Edwards Lifesciences (EW) Investment Story Is Shifting As Views On Growth Diverge - Yahoo Finance
Edwards Lifesciences Corp. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
Vanguard (NYSE: EW) reports 43.48M shares, 7.54% stake in Edwards Lifesciences - Stock Titan
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch
Mitsubishi UFJ Trust & Banking Corp Cuts Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Edwards CEO speaks May 12, with live webcast and same-day replay - Stock Titan
AMG National Trust Bank Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Vanguard Group Inc. Sells 283,775 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
에드워즈라이프사이언시스 (EW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.79%
자본화:
|
볼륨(24시간):